Multicentre Study Comparing Indwelling Pleural Catheter With Talc Pleurodesis for Malignant Pleural Effusion Management

January 24, 2014

Primary Outcome Measures:

Number of hospital days for all causes following intervention [ Time Frame: Up to 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Number of hospital days computed for pleural effusion related cause [ Time Frame: Up to 1 year ] [ Designated as safety issue: No ]
Number of adverse events [ Time Frame: Up to 1 year ] [ Designated as safety issue: Yes ]
Breathlessness score [ Time Frame: Up to 1 year ] [ Designated as safety issue: No ]
Self-reported quality of life scores [ Time Frame: Up to 1 year ] [ Designated as safety issue: No ]
Health costs computation [ Time Frame: Up to 1 year ] [ Designated as safety issue: No ]

Eligibility Criteria

Inclusion Criteria:

Symptomatic malignant pleural effusion requiring intervention

Exclusion Criteria:

<18 years of age
pregnant or lactating patients
expected survival <3 months
chylothorax
previous attempted pleurodesis
pleural infection
leukocytopaenia (<1.0 x 10^9/L)
uncorrectable bleeding diathesis
inability to give informed consent or comply with the protocol

CONTACT INFORMATION

Name*

First Last

Email*

Phone*

Address*

Street Address Address Line 2 City State / Province / Region ZIP / Postal Code Country

Have you received a diagnosis?*

Yes

DIAGNOSIS

Diagnosis?*

Date of Diagnosis*

Comments*

Comments

This field is for validation purposes and should be left unchanged.

Quick Facts

Accepts Healthy Volunteers
Ages Available for Study
ClinicalTrials.gov Identifier
Collaborators
Contacts(s)
Location(s)
Estimated Enrollment
Estimated Study Start Date
Estimated Primary Completion Dates
Full Title
Genders Eligible for Study
Investigator(s)
Last Updated
Other Contact